Results 151 to 160 of about 14,336 (185)
Maternal docosahexaenoic acid and eicosapentaenoic acid supplementation: effects and mechanisms on lipid metabolism in the offspring. [PDF]
Shao C +9 more
europepmc +1 more source
Exposure to Tebuconazole Drives Cross-Resistance to Clinical Triazoles in <i>Aspergillus fumigatus</i>. [PDF]
Meireles LM +3 more
europepmc +1 more source
The Multilayered Landscape of Ferroptosis: Plasticity, Propagation, and Evolutionary Perspectives. [PDF]
Chen H, Yan H, Bu H, Ye F.
europepmc +1 more source
Avasimibe Abolishes the Efficacy of Fluvastatin for the Prevention of Cancer in a Spontaneous Mouse Model of Breast Cancer. [PDF]
Bhardwaj A +7 more
europepmc +1 more source
Ferroptosis: biology and role in liver disease. [PDF]
Hino K, Nishina S, Yanatori I.
europepmc +1 more source
Cholesterol metabolism and cancer: Molecular mechanisms, immune regulation and an epidemiological perspective (Review). [PDF]
He Z, Zhang L, Gong S, Yang X, Xu G.
europepmc +1 more source
Organelle-specific regulation of ferroptosis. [PDF]
Zhang Y +8 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Prostaglandins & Other Lipid Mediators, 2021
Prostate cancer (PCa) is one of the most fatal malignant tumors that occurs in the prostate epithelium, especially in older men, the mortality of which ranks sixth among all cancer-related deaths. It has been urgently needed to elucidate the pathogenesis of PCa and provide promising therapeutic targets for PCa treatment. The Sterol O-acyltransferase 1 (
Yuan, Liu +4 more
openaire +2 more sources
Prostate cancer (PCa) is one of the most fatal malignant tumors that occurs in the prostate epithelium, especially in older men, the mortality of which ranks sixth among all cancer-related deaths. It has been urgently needed to elucidate the pathogenesis of PCa and provide promising therapeutic targets for PCa treatment. The Sterol O-acyltransferase 1 (
Yuan, Liu +4 more
openaire +2 more sources
Investigational New Drugs, 2020
Background Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with very limited treatment options. Nevanimibe HCl (formerly ATR-101), a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, has been shown in nonclinical studies to decrease adrenal steroidogenesis at lower doses and to cause apoptosis of adrenocortical ...
David C, Smith +11 more
openaire +2 more sources
Background Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy with very limited treatment options. Nevanimibe HCl (formerly ATR-101), a novel adrenal-specific sterol O-acyltransferase 1 (SOAT1) inhibitor, has been shown in nonclinical studies to decrease adrenal steroidogenesis at lower doses and to cause apoptosis of adrenocortical ...
David C, Smith +11 more
openaire +2 more sources

